Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dr. Reddy's Laboratories Ltd ADR (NY: RDY ) 15.11 +0.02 (+0.13%) Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Dr. Reddy's Laboratories Ltd ADR < Previous 1 2 3 4 5 6 Next > Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients May 25, 2022 This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market May 24, 2022 From Dr. Reddy’s Laboratories Ltd. Via Business Wire European Cannabis Q1 2022 Quarterly Update April 28, 2022 Just like the United States’ state-by-state movement, Europe is moving country-by-country toward providing access to cannabis. Via Talk Markets Dr. Reddy's Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U.S. Market April 20, 2022 From Dr. Reddy’s Laboratories Ltd. Via Business Wire Dr. Reddy's Laboratories Announces the Launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market April 05, 2022 From Dr. Reddy’s Laboratories Ltd. Via Business Wire Dr. Reddy's Laboratories & MediCane Health To Launch Medical Cannabis Products In Germany April 01, 2022 Dr. Reddy's Laboratories Ltd. (NYSE: RDY) and MediCane Health Inc. announced the launch of its medical cannabis product in Germany. Via Benzinga Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany April 01, 2022 From MediCane Health Inc. Via Business Wire Flood Helping Ukraine March 24, 2022 Emerging markets are gaining as mature markets look risky. Via Talk Markets Up On Bad News March 22, 2022 Despite the plane crash in China, Boeing's stock is up today. Via Talk Markets The Ruble Is Rubble March 03, 2022 MSCI says Russian companies are Via Talk Markets Putin on the brink February 28, 2022 For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott. Via Talk Markets Stocks That Hit 52-Week Lows On Wednesday March 02, 2022 Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 01, 2022 During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the... Via Benzinga Red Ink February 24, 2022 There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph Via Talk Markets Give peace a chance February 15, 2022 Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. Via Talk Markets Dr. Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market February 09, 2022 From Dr. Reddy’s Laboratories Ltd. Via Business Wire NYSE-Listed Pharma Co. Dr. Reddy's To Acquire German Medical Cannabis Firm Nimbus Health GmbH February 04, 2022 Pharmaceutical company Dr. Reddy's Laboratories Ltd. (NYSE:RDY) has entered into a definitive agreement to acquire Nimbus Health GmbH, a medical cannabis-focused licensed pharmaceutical wholesaler from... Via Benzinga Weakened Tech Stocks February 03, 2022 There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks. Via Talk Markets Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH February 03, 2022 From Dr. Reddy's Laboratories Ltd. Via Business Wire Dr. Reddy’s Included in S&P Global’s Sustainability Yearbook for the 2nd Year and Bloomberg Gender-Equality Index for the 5th Year in a Row February 02, 2022 From Dr. Reddy’s Laboratories Ltd. Via Business Wire The Last Day In January January 31, 2022 The market is suspicious of the moves up to right matters. Via Talk Markets Earnings Scheduled For January 28, 2022 January 28, 2022 Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its third quarter. • LyondellBasell Industries (NYSE:... Via Benzinga Reddy's To Launch Generic Version Of Merck's COVID-19 Drug At $0.50/Pill: Reuters January 04, 2022 India-based Dr Reddy's Laboratories Ltd (NYSE: RDY) will launch its generic version of Merck Co & Inc's (NYSE: MRK) COVID-19 antiviral pill, ... Via Benzinga Happy New Year - Sunday Edition January 02, 2022 Starting a new year - we look at tech, pharma and mining stocks and their goings-on. Via Talk Markets Market Trend: Erratic And Unreliable December 29, 2021 Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is. Via Talk Markets A Bit Of Good News December 22, 2021 US growth figures for Q3 were up from forecasts of 2.1% at 2.3% but well down from the prior quarter level of 6.7%. Via Talk Markets Dr. Reddy's Laboratories Announces the Launch of Venlafaxine ER Tablets in the U.S. Market December 09, 2021 From Dr. Reddy’s Laboratories Ltd. Via Business Wire Dr. Reddy's Laboratories Announces the Launch of Valsartan Tablets, USP in the U.S. Market December 09, 2021 From Dr. Reddy’s Laboratories Ltd. Via Business Wire Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia December 08, 2021 From Prestige BioPharma Ltd. Via Business Wire 5 Reasons Why Sensex Crashed, Tarsons Products' Lukewarm Debut, And Buzzing Stocks Today November 29, 2021 Indian share markets, which ended deep in the red on Friday, are headed for a gap-up opening today following the trend on SGX Nifty. Via Talk Markets < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
